1. AGHOKENG A. AND PEETERS M. Simian Immunodeficiency Viruses (SIVs) in Africa.   J Neurovirol  2005, 11 (Suppl 1):27-32
  1. AGHOKENG AF, EWANE L, AWAZI B, NANFACK A, DELAPORTE E, ZEKENG L AND PEETERS M. Enfuvirtide Binding Domain is Highly Conserved in non-B HIV type 1 Strains from Cameroon, West central Africa.  Aids Res Hum Retrovir 2005, 21(5): 430-433
  2. BOURGEOIS A, LAURENT C, MOUGNUTOU R, NKOUÉ N, LACTUOCK B, CIAFFI L, LIEGEOIS F, ANDRIEUX-MEYER I, ZEKENG L, CALMY A, MPOUDI-NGOLÉ E AND DELAPORTE E. Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon. Antiviral Therapy 2005, 10:335-341
  3. DJETCHA S., « Le sida, révélateur ou réformateur du social ? Le cas de la PTME au Cameroun », Terroirs, revue africaine de sciences sociales et de culture, coordonnée par F. Eboko, Yaoundé, 2005: 179-199
  4. EBOKO, F, Politique publique et sida en Afrique, de l’Anthropologie à la science politique. Cahiers d’Etudes africaines, XLV (2), 178, 2005, pp.331-387
  5. EBOKO, F, 2005, « Patterns of mobilization : political culture in the fight against AIDS » in Patterson, A., ed. The African state and the AIDS crisis. Aldershot, UK, ASHGATE, 37
  6. NJOUOM R, PASQUIER C, AYOUBA A, TEJIOKEM MC, VESSIERE A, MFOUPOUENDOUN J, TENE G, ETEKI N, MONNY LOBE M, IZOPET J, and NERRIENET E. (2005). Low risk of mother to child transmission of hepetitis C virus in Yaounde, Cameroon: The ANRS 1262 Study. J. Trop. Med. Hyg., 73 (2): 460-6 .
  7. ORSI F., CAMARA M., CORIAT B. (2006), “AIDS, TRIPS and “TRIPS plus” The case for Developing and Less Developed Countries”, (2005) in Andersen B, (Eds): Intellectual Property Rights: Innovation, Governance and the Institutional Environment, Oxford Press University
  8. PASQUIER C, NJOUOM R, VESSIERE A, AYOUBA A, TAGNI SARTRE M, SAUNÉ K, CARTERY M, TIMBA I, THONNON J, IZOPET J, and NERRIENET E. (2005). Heterogeneity and distribution of Hepatitis C genotypes in hepatitis patients in Cameroon. Med. Virol., 77: 390-8.